TR199701289T2 - Karbapenemlerin esterleri - Google Patents

Karbapenemlerin esterleri

Info

Publication number
TR199701289T2
TR199701289T2 TR97/01289T TR9701289T TR199701289T2 TR 199701289 T2 TR199701289 T2 TR 199701289T2 TR 97/01289 T TR97/01289 T TR 97/01289T TR 9701289 T TR9701289 T TR 9701289T TR 199701289 T2 TR199701289 T2 TR 199701289T2
Authority
TR
Turkey
Prior art keywords
group
optionally substituted
formula
substituted
hydrogen
Prior art date
Application number
TR97/01289T
Other languages
English (en)
Inventor
Burton George
Christopher Martin Fell Stephen
John Eglington Alfred
Frederich Moss Stephen
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508959.5A external-priority patent/GB9508959D0/en
Priority claimed from GBGB9508960.3A external-priority patent/GB9508960D0/en
Priority claimed from GBGB9508964.5A external-priority patent/GB9508964D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR199701289T2 publication Critical patent/TR199701289T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Asagidaki genel formül (I)'in bir bilesimi bakteryal enfeksiyonlarin tedavisinde yararlidir, burada R (a)'dir;Ra hidrojen, istege bagli olarak ikameli (C1-6) alkil ya da istege bagli olarak ikameli arildir; R ; hidrojen, istege bagli olarak ikameli arildir ya da Ra ve R birlikte ek hetero atomsuz, istege bagli olarak ikameli 5 ya da 6 elemanli heterosiklik halka olusturur; R1; ikamesiz ya da floro ile ikameli (C1-6) alkil istege bagli olarak kolayca ayrilabilen hidroksi koruma grubu ya da bir amino koruma grubu ile kolayca korunabilen bir amino grubu ile korunan bir hidroksi grubudur; R2 ya da metildir; ve R3 formül (i) (a) grubudan ve formül CH(Ra) O.CO.Rb'den olusan gruptan seçilir.
TR97/01289T 1995-05-03 1996-05-02 Karbapenemlerin esterleri TR199701289T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508959.5A GB9508959D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508960.3A GB9508960D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508964.5A GB9508964D0 (en) 1995-05-03 1995-05-03 Novel compounds

Publications (1)

Publication Number Publication Date
TR199701289T2 true TR199701289T2 (tr) 1998-08-21

Family

ID=27267697

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01289T TR199701289T2 (tr) 1995-05-03 1996-05-02 Karbapenemlerin esterleri

Country Status (14)

Country Link
EP (1) EP0823911A1 (tr)
JP (1) JPH11504912A (tr)
KR (1) KR19990008354A (tr)
CN (1) CN1184480A (tr)
AU (1) AU5814196A (tr)
BR (1) BR9608318A (tr)
CA (1) CA2217885A1 (tr)
CZ (1) CZ347697A3 (tr)
HU (1) HUP9801061A3 (tr)
MX (1) MX9708422A (tr)
NO (1) NO974995L (tr)
PL (1) PL323148A1 (tr)
TR (1) TR199701289T2 (tr)
WO (1) WO1996034869A1 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100771019B1 (ko) * 2002-03-20 2007-10-29 주식회사 만도 브레이크 액압제어장치
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK637888A (da) * 1987-11-24 1989-05-25 Hoffmann La Roche Carboxylsyreestere
GB8809534D0 (en) * 1988-04-22 1988-05-25 Beecham Group Plc Novel compounds
CN1167486A (zh) * 1993-10-29 1997-12-10 史密斯克莱·比奇曼公司 2-(吡唑-3-基)碳代青霉烯衍生物

Also Published As

Publication number Publication date
JPH11504912A (ja) 1999-05-11
MX9708422A (es) 1998-02-28
EP0823911A1 (en) 1998-02-18
WO1996034869A1 (en) 1996-11-07
NO974995D0 (no) 1997-10-30
CA2217885A1 (en) 1996-11-07
CZ347697A3 (cs) 1998-06-17
KR19990008354A (ko) 1999-01-25
NO974995L (no) 1997-10-30
CN1184480A (zh) 1998-06-10
AU5814196A (en) 1996-11-21
HUP9801061A3 (en) 1999-01-28
HUP9801061A2 (hu) 1998-08-28
BR9608318A (pt) 1999-01-26
PL323148A1 (en) 1998-03-16

Similar Documents

Publication Publication Date Title
TR199700844T1 (tr) Pirazolil-Benzoil Türevleri.
DE69615002D1 (de) Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
EA199800141A1 (ru) Гетероциклические соединения
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
TR199701728T1 (tr) Sialil-Lewis X ve sialil-Lewis A taklitleri olarak digikosilatlanmis 1,-2-dioller.
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
PT947504E (pt) Derivados de vitamina d 16-eno
DE69719511T2 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
GB9426090D0 (en) Pharmaceutical compounds
TR199701289T2 (tr) Karbapenemlerin esterleri
FI953784A0 (fi) 3'-atsiridinoantrasykliinijohdannaiset
TR199700802T2 (tr) Triazin türevleri.
ATE225335T1 (de) Amide derivate als 5-ht1a liganden
TW354780B (en) 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
AU4486796A (en) Imidazole derivatives, their preparation and their use as sadenosylmethionine decarboxylase (=samdc) inhibitors
AU8223991A (en) New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin iib
DE69402021T2 (de) Verzweigte aminooxy-amino-alkan-derivate als ornithin-decarboxylase inhibitoren
TR199701286T1 (tr) Karbapenemlerin esterleri.
TW349092B (en) Substituted indole derivatives